GLP-1 agonists have become a game-changing topic in healthcare, offering employers a promising new way to better manage diabetes and obesity. These treatments hold the potential for improving employee health and satisfaction, reducing absenteeism, and boosting productivity.
Join us and your peers for an engaging evening where we’ll explore the latest developments, innovative benefit strategies, and proven best practices to help you support your workforce more effectively.
Don’t miss this opportunity to get an in-depth look into the GLP-1 research pipeline and future indications as well as actionable insights from leading experts!
